N-acetylmuramoyl-L-alanine amidase is a biomarker for remission of type 2 diabetes after bariatric surgery

Autor:	Anthony Wetton, Rachelle Donn, Bethany Geary, Helene A Fachim, Adrian Heald, Alan Campbell, Akheel A. Syed, J. M. Gibson, Handrean Soran, Zohaib Iqbal, Ivona Baricevic-Jones
Rok vydání:	2021
Předmět:	medicine.medical_specialty business.industry Internal medicine Biomarker (medicine) Medicine Type 2 diabetes business medicine.disease N-acetylmuramoyl-L-alanine amidase Gastroenterology
Zdroj:	Endocrine Abstracts.
ISSN:	1479-6848
DOI:	10.1530/endoabs.77.p192
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::aacc95847a9068c8b2c06b696e6303da https://doi.org/10.1530/endoabs.77.p192 Zobrazit plný text záznamu